Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lower-dose aspirin regimen comparison after acute coronary syndrome
2016-000920-25Phase 4Completed
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Start
- Jun 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of aspirin and ticagrelor in acute coronary syndrome (ACS) (2 arms), sponsored by Sheffield Teaching Hospitals NHS Foundation Trust. Primary endpoints: Co-primary outcome measures and Thromboxane and prostacyclin metabolites. Started Jun 2018; status: completed.
02
Drugs
aspirinticagrelor
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on 2016-000920-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000920-25.